.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Harvard Business School
Fuji
Johnson and Johnson
Cipla
Covington
Chinese Patent Office
Dow
Baxter
McKesson

Generated: November 24, 2017

DrugPatentWatch Database Preview

Igi Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for IGI LABS INC, and what generic and branded alternatives to IGI LABS INC drugs are available?

IGI LABS INC has fifty-three approved drugs.

There is one tentative approval on IGI LABS INC drugs.

Summary for Igi Labs Inc

US Patents:0
Tradenames:13
Ingredients:13
NDAs:53
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Igi Labs Inc
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
INJECTABLE;INJECTION070094-001Oct 23, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
MEPERIDINE HYDROCHLORIDE
meperidine hydrochloride
INJECTABLE;INJECTION089781-001Mar 31, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
NALOXONE HYDROCHLORIDE
naloxone hydrochloride
INJECTABLE;INJECTION072083-001Apr 11, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
INJECTABLE;INJECTION070087-001Oct 23, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
FUROSEMIDE
furosemide
INJECTABLE;INJECTION070095-001Sep 9, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
NALOXONE HYDROCHLORIDE
naloxone hydrochloride
INJECTABLE;INJECTION072089-001Apr 11, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
DROPERIDOL
droperidol
INJECTABLE;INJECTION072020-001Oct 19, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
MEPERIDINE HYDROCHLORIDE
meperidine hydrochloride
INJECTABLE;INJECTION089785-001Mar 31, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION063121-001Oct 31, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Igi Labs Inc
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION063122-001Oct 31, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
McKesson
Harvard Business School
Colorcon
UBS
Accenture
US Department of Justice
AstraZeneca
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot